Home > Research > Publications & Outputs > Coping strategies of patients with advanced lun...


Text available via DOI:

View graph of relations

Coping strategies of patients with advanced lung or colorectal cancer in six European countries: Insights from the ACTION Study

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • L.J. Jabbarian
  • I.J. Korfage
  • B. Červ
  • J.J.M. van Delden
  • L. Deliens
  • G. Miccinesi
  • S. Payne
  • A. Thit Johnsen
  • M.N. Verkissen
  • A. Wilcock
  • A. van der Heide
  • J.A.C. Rietjens
<mark>Journal publication date</mark>1/02/2020
Issue number2
Number of pages9
Pages (from-to)347-355
Publication StatusPublished
Early online date20/11/19
<mark>Original language</mark>English


Objective: Even when medical treatments are limited, supporting patients’ coping strategies could improve their quality of life. Greater understanding of patients’ coping strategies, and influencing factors, can aid developing such support. We examined the prevalence of coping strategies and associated variables. Methods: We used sociodemographic and baseline data from the ACTION trial, including measures of Denial, Acceptance, and Problem-focused coping (COPE; Brief COPE inventory), of patients with advanced cancer from six European countries. Clinicians provided clinical information. Linear mixed models with clustering at hospital level were used. Results: Data from 675 patients with stage III/IV lung (342, 51%) or stage IV colorectal (333, 49%) cancer were used; mean age 66 (10 SD) years. Overall, patients scored low on Denial and high on Acceptance and Problem-focused coping. Older age was associated with higher scores on Denial than younger age (β = 0.05; CI[0.023; 0.074]), and patients from Italy (β = 1.57 CI[0.760; 2.388]) and Denmark (β = 1.82 CI[0.881; 2.750]) scored higher on Denial than patients in other countries. Conclusions: Patients with advanced cancer predominantly used Acceptance and Problem-focused coping, and Denial to a lesser extent. Since the studied coping strategies of patients with advanced cancer vary between subpopulations, we recommend taking these factors into account when developing tailored interventions to support patients’ coping strategies.